Email to GenScript
 
Search by Catalog Number :
Search by Name :
Search by Sequence : (One letter code)
Search by Category :



Platelet Factor-4/CXCL4(PF-4/CXCL4), Human




Protein Platelet Factor-4/CXCL4(PF-4/CXCL4), Human
Synonyms
PF 4 Human; rHuPF-4/CXCL4
Documents
Platelet Factor-4/CXCL4(PF-4/CXCL4), HumanDocument-MSDS: Z03026_MSDS.pdf (pdf)
Purity
>97% by SDS-PAGE and HPLC analyses.
Endotoxin Level
Less than 0.2EU/μg of rHuPF-4/CXCL4 as determined by LAL method.
Biological Activity
Fully biologically active when compared to standard. The ED50 determined by inhibiting human FGF-basic-dependent proliferation ofmurine NR6R/3T3 cells is less than 15000 ng/ml, corresponding to a specific activity of > 66.7 IU/mg.
Source
Escherichia coli.
Amino Acid Sequence
EAEEDGDLQC LCVKTTSQVR PRHITSLEVI KAGPHCPTAQ
LIATLKNGRK ICLDLQAPLY KKIIKKLLES
Molecular Weight
Approximately 7.77 kDa, a single non-glycosylated polypeptide chain containing 70 amino acids.
Description
Platelet Factor 4, is a member of the CXC chemokine family, CXCL4. CXCL4 has homology with IL8 and βthromboglobulin.The active protein consists of a tetramer composed of individual CXCL4 subunits. Megakaryocytes synthesize CXCL4 and store it as tetramers in α-granules. The CXCL4 tetramers are secreted by activated platelets and can be measured at micromolar levels in serum. In contrast to other CXC chemokines, CXCL4 lacks chemotactic activity for polymorphonuclear granulocytes. CXCL4 does not contain an ELR motif. However, many other functions have been observed for CXCL4. CXCL4 is involved in monocyte survivial and differentiation into macrophages, and it has antiangiogenic activity. CXCL4 has been demonstrated to inhibit the binding of FGF2 to highaffinity receptors and its subsequent internalization. Cell surface neutrophil chondroitin sulfate chains serve as CXCL4 binding sites; affinity is controlled by the degree of sulfation of these chains.
Formulation
Lyophilized from a 0.2um filtered concentrated solution in 20mM PB, 1.5M NaCl, pH 7.4.
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at <-20℃. Further dilutions should be made in appropriate buffered solutions.
Storage
This lyophilized preparation is stable at 2-8℃, but should be kept at -20℃ for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8℃. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20℃ to -70℃. Avoid repeated freeze/thaw cycles.
Document-COA
  • B60141323_Z03026_COA
  • 1
    Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 .
    2
    Bacterial Expression System: GenScript has developed BacPowerTM technologies to tackle hard-to-express and hard-to-dissolve proteins.
    3
    Yeast Expression System: GenScript's proprietary YeastHIGHTM technology combines the advantages of the bacterial and eukaryotic expression systems.
    4
    Baculovirus/Insect Cell Expression System: GenScript developed BacuVanceTM platform for the secretion of recombinant proteins from baculovirus-infected insect cells.
    5
    Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level.